Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ocular Hypertension: full-pipeline trial registry
12 of 57 indexed Ocular Hypertension trials are currently recruiting.
Corpus placement: #249 of 28,707 conditions by registered trial count.
57 US clinical trials · 12 currently recruiting · #249 of 28,707 conditions by registered trial count
Ocular Hypertension: 57 US clinical trials tracked, 12 recruiting.
Ocular Hypertension is the subject of 57 registered US clinical trials on ClinicalTrials.gov, 12 of them currently open to new participants. 26 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is Allergan, running 9 of these trials.
Enrollment posture brief
Registry condition ocular-hypertension
OPEN 12 | RECR 21% | LATE 26 | EARLY 21 | RANK #249 | SPON 9
Volume-matched condition peers
Nearest open-share peer: Hodgkin's Lymphoma (21% recruiting · 19 trials)
Ocular Hypertension lists 12 open slots (21% of 57 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ocular Hypertension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ocular Hypertension is recruiting below its size-band peers.
12 of 57 indexed trials (21.1%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Ocular Hypertension research.
Allergan accounts for 9 of 57 trials (15.8%). 36 distinct sponsors appear on at least one study for this condition label.
-
Typical Ocular Hypertension enrolment sits around 164 participants.
Median target enrolment is 164 among the 55 trials that report a genuine target (sentinel values excluded). 20 of those (36.4%) plan for fewer than 100 participants.
-
Ocular Hypertension research is mostly interventional.
51 interventional and 6 observational studies make up this index (89.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
57 total, page 2 of 2
Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure
University of Colorado, Denver
NCT01779778
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects
University of Wisconsin, Madison
NCT01864642
The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width
University of Houston
NCT03926975
Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma
Stanford University
NCT04035239
Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects
Noveome Biotherapeutics, formerly Stemnion
NCT03901781
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
Alcon Research
NCT00051155
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
Alcon Research
NCT00047541
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 11 |
| Phase 3 | 21 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Ocular Hypertension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ocular Hypertension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ocular Hypertension page
57 registered trials, 12 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 12 Ocular Hypertension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Allergan sponsors the most Ocular Hypertension trials on record, review their full trial history before evaluating a specific study. See Allergan's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ocular Hypertension condition card totals 57 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.